Both Eli Lilly $LLY (-2,32 %) and Novo Nordisk $NVO (-0,97 %) are disrupting the diet industry with their GLP-1 drugs, offering the potential for significant growth in the future.

$LLY (-2,32 %) is on track to become the first trillion dollar drug-maker...😯